Thursday, August 06, 2020 4:27:08 PM
SPPI some DD must read
if we get approval for Oct pdufa.
Here you can see the competitor with drug on the market. 1Q earnings from this drug.
If we get 1/3 of the market that amgen had.
Than we have income of 1B$ per year
And only from one drug. We have a good pipline. From 3.5$ I think easy 5 to 10bagger if we get approval and cohort3 will have good data
from last Qs they have 40. 6M net loss and cash on hand around 177.8M
??So we have cash for about 1 year.
Still safe for top line date of cohort3 in the second half.
And pdufa data in Oct. Market size 3B US
if we get approval for Oct pdufa.
Here you can see the competitor with drug on the market. 1Q earnings from this drug.
If we get 1/3 of the market that amgen had.
Than we have income of 1B$ per year
And only from one drug. We have a good pipline. From 3.5$ I think easy 5 to 10bagger if we get approval and cohort3 will have good data
from last Qs they have 40. 6M net loss and cash on hand around 177.8M
??So we have cash for about 1 year.
Still safe for top line date of cohort3 in the second half.
And pdufa data in Oct. Market size 3B US
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
